Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.

Mirena

Last reviewed on RxList: 9/3/2020
Mirena Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

What Is Mirena?

Mirena (levonorgestrel-releasing intrauterine device) is a form of birth control that is indicated for intrauterine contraception for up to 5 years and for the treatment of heavy menstrual bleeding in women. Mirena is a hormone-releasing system placed in your uterus (intra-uterine device, or IUD) to prevent pregnancy for up to 5 years.

What Are Side Effects of Mirena?

Common side effects of Mirena are:

  • missed periods (amenorrhea),
  • bleeding and spotting between periods,
  • heavier bleeding during the first few weeks after device insertion,
  • abdominal/pelvic pain,
  • ovarian cysts,
  • back pain,
  • headache/migraine,
  • nervousness,
  • dizziness,
  • nausea,
  • vomiting,
  • bloating,
  • breast tenderness or pain,
  • weight gain,
  • changes in hair growth,
  • acne,
  • depression,
  • changes in mood,
  • loss of interest in sex,
  • itching or skin rash, and
  • puffiness in the face, hands, ankles, or feet.

Dosage for Mirena

Mirena contains 52 mg of levonorgestrel (LNG). Initially, LNG is released at a dose rate of approximately 20 mcg/day. This rate decreases progressively to half that value after 5 years. Mirena must be removed by the end of the fifth year and can be replaced at the time of removal with a new Mirena if continued contraceptive protection is desired.

What Drugs, Substances, or Supplements Interact with Mirena?

Drug interactions and warnings include potential interactions with insulin, warfarin (Coumadin) and steroids. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors.

Mirena During Pregnancy and Breastfeeding

Mirena should not be used during pregnancy. This device can cause severe infection, miscarriage, premature birth, or death of the mother if it is left in place during pregnancy. Tell your doctor right away if you become pregnant while using the Mirena intrauterine system. Small amounts of progestins such as those in Mirena pass into breast milk. If you have recently had a baby and are breastfeeding, wait until your baby is at least 6 weeks old before you start using Mirena.

Additional Information

Our Mirena Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

QUESTION

Which of the following are methods for contraception? See Answer
Mirena Consumer Information

3 pharmacies near 20147 have coupons for Kyleena (Brand Names:Mirena for 1 Intrauterine Device)

CVS Pharmacy
CVS Pharmacy
$928.99

Est. Regular Price

$879.14

with free coupon

View Coupon
Walgreens
Walgreens
$928.99

Est. Regular Price

$894.93

with free coupon

View Coupon
Harris Teeter Pharmacy
Harris Teeter Pharmacy
$928.99

Est. Regular Price

$905.07

with free coupon

View Coupon

Get emergency medical help if you have severe pain in your lower stomach or side. This could be a sign of a tubal pregnancy (a pregnancy that implants in the fallopian tube instead of the uterus). A tubal pregnancy is a medical emergency.

The levonorgestrel IUD may become embedded into the wall of the uterus, or may perforate (form a hole) in the uterus. If this occurs, the device may no longer prevent pregnancy, or it may move outside the uterus and cause scarring, infection, or damage to other organs. Your doctor may need to surgically remove the device.

Call your doctor at once if you have:

  • severe cramps or pelvic pain, pain during sexual intercourse;
  • extreme dizziness or light-headed feeling;
  • severe migraine headache;
  • heavy or ongoing vaginal bleeding, vaginal sores, vaginal discharge that is watery, foul-smelling discharge, or otherwise unusual;
  • pale skin, weakness, easy bruising or bleeding, fever, chills, or other signs of infection;
  • sudden numbness or weakness (especially on one side of the body), confusion, problems with vision, sensitivity to light;
  • jaundice (yellowing of the skin or eyes); or
  • signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Common side effects may include:

  • pelvic pain, vaginal itching or infection, irregular menstrual periods, changes in bleeding patterns or flow;
  • stomach pain, nausea, vomiting, bloating;
  • headache, depression, mood changes;
  • back pain, breast tenderness or pain;
  • weight gain, acne, changes in hair growth, loss of interest in sex; or
  • puffiness in your face, hands, ankles, or feet.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Mirena (Levonorgestrel-Releasing Intrauterine System)

SLIDESHOW

Choosing Your Birth Control Method See Slideshow
Mirena Professional Information

SIDE EFFECTS

The following serious or otherwise important adverse reactions are discussed in elsewhere in the labeling:

  • Ectopic Pregnancy [see WARNINGS AND PRECAUTIONS]
  • Intrauterine Pregnancy [see WARNINGS AND PRECAUTIONS]
  • Group A Streptococcal Sepsis (GAS) [see WARNINGS AND PRECAUTIONS]
  • Pelvic Inflammatory Disease [see WARNINGS AND PRECAUTIONS]
  • Alterations of Bleeding Patterns [see WARNINGS AND PRECAUTIONS]
  • Perforation [see WARNINGS AND PRECAUTIONS]
  • Expulsion [see WARNINGS AND PRECAUTIONS]
  • Ovarian Cysts [see WARNINGS AND PRECAUTIONS]

Clinical Trials Experience

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

The data provided in Table 2 reflect the experience with the use of Mirena in the adequate and well-controlled studies as well as in the supportive and uncontrolled studies for contraception and heavy menstrual bleeding (n=5,091). The data cover more than 12,101 women-years of exposure up to 5 years of use, mainly in the contraception studies (11,761 women-years). The frequencies of reported adverse drug reactions represent crude incidences.

The most common adverse reactions (≥10% users) are alterations of menstrual bleeding patterns [including unscheduled uterine bleeding (31.9%), decreased uterine bleeding (23.4%), increased scheduled uterine bleeding (11.9%), and female genital tract bleeding (3.5%)], abdominal/pelvic pain (22.6%), amenorrhea (18.4%), headache/migraine (16.3%), genital discharge (14.9%), and vulvovaginitis (10.5%). Adverse reactions reported in ≥ 5% of users are shown in Table 2.

Table 2 Adverse Reactions ≥ 5% Reported in Clinical Trials with Mirena

System Organ ClassAdverse Reactions% (N= 5,091)
Reproductive system and breast disordersalteration of menstrual bleeding pattern, including:
unscheduled uterine bleeding31.9
decreased uterine bleeding23.4
increased scheduled uterine bleeding11.9
female genital tract bleeding3.5
amenorrhea18.4
genital discharge14.9
vulvovaginitis10.5
breast pain8.5
benign ovarian cyst and associated complications7.5
dysmenorrhea6.4
Gastrointestinal disordersabdominal/pelvic pain22.6
Nervous system disordersheadache/migraine16.3
Musculoskeletal and connective tissue disordersback pain7.9
Skin and subcutaneous tissue disordersacne6.8
Psychiatric disordersdepression/depressive mood6.4

Other adverse reactions occurring in <5% of subjects include alopecia, (partial and complete) device expulsion, hirsutism, nausea, and PID/endometritis.

A separate study with 362 women who have used Mirena for more than 5 years showed a consistent adverse reaction profile in Year 6. By the end of Year 6 of use, amenorrhea and infrequent bleeding are experienced by 24% and 31% of users, respectively; irregular bleeding occurs in 15%, and prolonged bleeding in 2% of users.

Postmarketing Experience

The following adverse reactions have been identified during post approval use of Mirena. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

  • Arterial thrombotic and venous thromboembolic events, including cases of pulmonary emboli, deep vein thrombosis and stroke
  • Device breakage
  • Hypersensitivity (including rash, urticaria and angioedema)
  • Increased blood pressure

Read the entire FDA prescribing information for Mirena (Levonorgestrel-Releasing Intrauterine System)

Health Solutions From Our Sponsors